Clin2
NCT06600711Possibly a fitNot yet recruiting

Nitazoxanide for treating cryptosporidium infection in children

Cryptosporidiosis

Treatments studied

Part of Digestive system, Infections clinical trials.

This study tests a medicine called nitazoxanide to treat cryptosporidium, a germ that can cause diarrhea in children. If your child tests positive for this germ, the treatment may help clear the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
480 people
Ages
6 months to 1 year
Study type
Interventional

Who can take part

  • Your child must have tested positive for cryptosporidium using a stool test (even if they don't have diarrhea right now).
  • Your family plans to stay in the area for the next 6 months.
  • Your child must not have a known allergy to nitazoxanide.
  • Your child cannot be taking warfarin, a blood-thinning medicine.
  • Your child must not have kidney or liver problems (as determined by a doctor through blood tests).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07249463Recruiting· Phase 2
Testing a new drug for cryptosporidium infection in healthy adults

This trial tests a new drug, EDI048, to see how well it works and how safe it is for treating cryptosporidium infection. It is for healthy volunteers who will be intentionally exposed to the infection under controlled conditions.

Baltimore, Maryland
NCT07716410Recruiting
Study of Cryptosporidium in Children with Diarrhea

This study follows children aged 6 months to 5 years with diarrhea caused by Cryptosporidium. It aims to understand how the infection develops over time and how it affects children.

Kisumu, Nyanza
NCT04415983Recruiting· Phase 3
Nitazoxanide for stomach infection in children

This trial studies nitazoxanide to treat Helicobacter pylori, a common stomach infection, in children. If you test positive for this infection and haven’t been treated for it before, you may be able to join.

Tanta
NCT07808450Not yet recruiting· Phase 1/Phase 2
Nitazoxanide for infection of belly fluid in cirrhosis

This trial is testing whether an antiparasitic medicine called nitazoxanide can help treat a type of infection in the belly fluid that happens in people with liver cirrhosis. If you have cirrhosis and this infection, joining might give you access to a new treatment option.

NCT07820046Not yet recruiting· Phase 2/Phase 3
Nitazoxanide added to usual care for mild-to-moderate ulcerative colitis

This study tests whether adding nitazoxanide, an anti-parasitic medicine, to your current ulcerative colitis treatment helps reduce inflammation and symptoms. It may offer an extra option for people with mild-to-moderate disease.

NCT06817096Not yet recruiting· Phase 3
Nitazoxanide for mild COVID-19 or flu

This trial tests whether the medicine nitazoxanide, taken as a pill, can help people with mild COVID-19 or flu feel better faster and prevent complications. It is designed for people who are generally healthy and can be treated at home.

Hear when a new Cryptosporidiosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.